Showing 701-710 of 3506 results for "".
Stirring the Pot: Cannabinoids and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/stirring-the-pot-cannabinoids-and-atopic-dermatitis/20565/Cannabinoids are a diverse group of compounds that may hold significant therapeutic capabilities applicable to many areas of medicine, including dermatology.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-18/23367/Dermatologists Are Taking Action in Their Fight Against MOC
https://practicaldermatology.com/topics/practice-management/dermatologists-are-taking-action-in-their-fight-against-moc/20641/Maintenance of Certification (MOC) continues to be a thorny topic for some medical practitioners— and that may be stating the case mildly.Lead Psoriasis Patients Along the Path to Clearance
https://practicaldermatology.com/topics/psoriasis/PD0209_01-php/22873/With so many effective therapies now available, dermatologists must be prepared to guide their patients to the right treatment for their specific presentation.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-15/23311/Current Sunscreen Controversies Impeding Patient Compliance
https://practicaldermatology.com/topics/practice-management/current-sunscreen-controversies-impeding-patient-compliance/20992/Patient concerns should not prevent the physician from advising adequate sunscreen use.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-33/23690/New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21688/Clinical Updates on Psoriasis Management
https://practicaldermatology.com/topics/psoriasis/clinical-updates-on-psoriasis-management/21496/Update on Atopic Dermatitis 2018
https://practicaldermatology.com/topics/general-topics/update-on-atopic-dermatitis-2018/20354/A look at the pathophysiology of AD, including structural and immunologic contributors, as well as new therapeutic developments with an eye toward breakthroughs on the horizon.